Literature DB >> 15542518

Human lymphocyte stimulation with pouchitis flora is greater than with flora from a healthy pouch but is suppressed by metronidazole.

A J G Bell1, R J Nicholls, A Forbes, H J Ellis, P J Ciclitira.   

Abstract

BACKGROUND/AIMS: The gut flora may play an important role in the pathogenesis of inflammatory bowel disease. An ileal reservoir or pouch can be created to replace the excised rectum after proctocolectomy. In patients with ulcerative colitis this is subject to inflammation and termed pouchitis. Using bacteria from patients the authors sought evidence for the presence rather than the identity of a pathogenic species in pouchitis, and for its absence in healthy pouches by the differential effect on lymphocyte proliferation.
METHODS: An ex vivo cell culture assay was used in which peripheral blood mononuclear cells or lamina propria mononuclear cells were cultured with sterile sonicates of gut flora from patients with or without pouchitis in the presence of antigen presenting cells.
RESULTS: Sonicated pouchitis flora produced a consistent and intense proliferation of the mononuclear cells but that produced by sonicates from healthy pouches was minimal (p = 0.012 or 0.018, peripheral blood or lamina propria mononuclear cells). Preparation of the sonicates with the antibiotic metronidazole abolished their stimulatory ability (p = 0.005, peripheral blood mononuclear cells). In separate assays neither direct addition of metronidazole nor of its hydroxy metabolite affected the mononuclear cells' proliferation with alternative stimuli.
CONCLUSIONS: These results strongly support a bacterial aetiology for pouchitis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15542518      PMCID: PMC1774306          DOI: 10.1136/gut.2003.026807

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  40 in total

Review 1.  Bacteria as the cause of ulcerative colitis.

Authors:  M Campieri; P Gionchetti
Journal:  Gut       Date:  2001-01       Impact factor: 23.059

Review 2.  Microbial factors in inflammatory bowel disease.

Authors:  Richard J Farrell; J Thomas LaMont
Journal:  Gastroenterol Clin North Am       Date:  2002-03       Impact factor: 3.806

3.  Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis.

Authors:  T Ohkusa; I Okayasu; T Ogihara; K Morita; M Ogawa; N Sato
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

4.  Effects of metronidazole on certain functions of human blood neutrophils and lymphocytes.

Authors:  R Anderson; R Oosthuizen; C Maritz; A Theron; A J Van Rensburg
Journal:  S Afr Med J       Date:  1979-04-07

5.  Proctocolectomy without ileostomy for ulcerative colitis.

Authors:  A G Parks; R J Nicholls
Journal:  Br Med J       Date:  1978-07-08

6.  Mucosal flora in inflammatory bowel disease.

Authors:  Alexander Swidsinski; Axel Ladhoff; Annelie Pernthaler; Sonja Swidsinski; Vera Loening-Baucke; Marianne Ortner; Jutta Weber; Uwe Hoffmann; Stefan Schreiber; Manfred Dietel; Herbert Lochs
Journal:  Gastroenterology       Date:  2002-01       Impact factor: 22.682

7.  Targeting enteric bacteria in treatment of inflammatory bowel diseases: why, how, and when.

Authors:  R Balfour Sartor
Journal:  Curr Opin Gastroenterol       Date:  2003-07       Impact factor: 3.287

8.  Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial.

Authors:  Paolo Gionchetti; Fernando Rizzello; Ulf Helwig; Alessandro Venturi; Karen Manon Lammers; Patrizia Brigidi; Beatrice Vitali; Gilberto Poggioli; Mario Miglioli; Massimo Campieri
Journal:  Gastroenterology       Date:  2003-05       Impact factor: 22.682

9.  Detection and verification of Mycobacterium avium subsp. paratuberculosis in fresh ileocolonic mucosal biopsy specimens from individuals with and without Crohn's disease.

Authors:  Tim J Bull; Elizabeth J McMinn; Karim Sidi-Boumedine; Angela Skull; Damien Durkin; Penny Neild; Glenn Rhodes; Roger Pickup; John Hermon-Taylor
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

10.  Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)

Authors:  R Duchmann; I Kaiser; E Hermann; W Mayet; K Ewe; K H Meyer zum Büschenfelde
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

View more
  7 in total

1.  The bacterial pathogenesis and treatment of pouchitis.

Authors:  S D McLaughlin; S K Clark; P P Tekkis; R J Nicholls; P J Ciclitira
Journal:  Therap Adv Gastroenterol       Date:  2010-11       Impact factor: 4.409

Review 2.  Probiotics and inflammatory bowel diseases.

Authors:  A-P Bai; Q Ouyang
Journal:  Postgrad Med J       Date:  2006-06       Impact factor: 2.401

Review 3.  Relationship between pouch microbiota and pouchitis following restorative proctocolectomy for ulcerative colitis.

Authors:  Imerio Angriman; Marco Scarpa; Ignazio Castagliuolo
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

4.  The bacteriology of pouchitis: a molecular phylogenetic analysis using 16S rRNA gene cloning and sequencing.

Authors:  Simon D McLaughlin; Alan W Walker; Carol Churcher; Susan K Clark; Paris P Tekkis; Matthew W Johnson; Julian Parkhill; Paul J Ciclitira; Gordon Dougan; Ralph John Nicholls; Liljana Petrovska
Journal:  Ann Surg       Date:  2010-07       Impact factor: 12.969

Review 5.  Pouchitis.

Authors:  En-Da Yu; Zhuo Shao; Bo Shen
Journal:  World J Gastroenterol       Date:  2007-11-14       Impact factor: 5.742

6.  Long-term alteration of intestinal microbiota in patients with ulcerative colitis by antibiotic combination therapy.

Authors:  Shigeo Koido; Toshifumi Ohkusa; Takayuki Kajiura; Junko Shinozaki; Manabu Suzuki; Keisuke Saito; Kazuki Takakura; Shintaro Tsukinaga; Shunichi Odahara; Toyokazu Yukawa; Jimi Mitobe; Mikio Kajihara; Kan Uchiyama; Hiroshi Arakawa; Hisao Tajiri
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

Review 7.  The Microbiome as a Therapy in Pouchitis and Ulcerative Colitis.

Authors:  Jean-Frédéric LeBlanc; Jonathan P Segal; Lucia Maria de Campos Braz; Ailsa L Hart
Journal:  Nutrients       Date:  2021-05-23       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.